11/21
04:05 pm
nmra
Form 8-K Neumora Therapeutics, For: Nov 17
Medium
Report
Form 8-K Neumora Therapeutics, For: Nov 17
11/12
07:55 pm
nmra
Form 144 Neumora Therapeutics, Filed by: Aurora Daljit Singh
Medium
Report
Form 144 Neumora Therapeutics, Filed by: Aurora Daljit Singh
11/6
04:03 pm
nmra
Form 10-Q Neumora Therapeutics, For: Sep 30
Low
Report
Form 10-Q Neumora Therapeutics, For: Sep 30
11/6
07:05 am
nmra
Form 8-K Neumora Therapeutics, For: Nov 06
Low
Report
Form 8-K Neumora Therapeutics, For: Nov 06
10/29
07:22 pm
nmra
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: Burow Kristina
High
Report
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: Burow Kristina
10/29
07:21 pm
nmra
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: ARCH Venture Fund XII, L.P.
High
Report
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: ARCH Venture Fund XII, L.P.
10/29
07:19 pm
nmra
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: ARCH Venture Partners X, LLC
High
Report
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: ARCH Venture Partners X, LLC
10/29
07:07 pm
nmra
Form SCHEDULE 13D/A Neumora Therapeutics, Filed by: ARCH Venture Fund XII, L.P.
High
Report
Form SCHEDULE 13D/A Neumora Therapeutics, Filed by: ARCH Venture Fund XII, L.P.
10/27
07:02 am
nmra
Form 8-K Neumora Therapeutics, For: Oct 27
Medium
Report
Form 8-K Neumora Therapeutics, For: Oct 27
10/27
06:34 am
nmra
Form 8-K Neumora Therapeutics, For: Oct 27
Low
Report
Form 8-K Neumora Therapeutics, For: Oct 27